Is osteopontin a promising prognostic biomarker for cholangiocarcinoma?
作者信息
Wu Han, Zhang Han, Hu Lun-Yang, Zhang Tian-Yi, Zheng Yi-Jie, Shen Feng, Yang Tian
机构信息
Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China; Department of Clinical Medicine, Second Military Medical University, Shanghai 200433, China.
出版信息
J Hepatol. 2017 Sep 20. doi: 10.1016/j.jhep.2017.08.029.
PMID:28870677
Abstract
摘要
相似文献
1
Is osteopontin a promising prognostic biomarker for cholangiocarcinoma?骨桥蛋白是胆管癌有前景的预后生物标志物吗？
J Hepatol. 2017 Sep 20. doi: 10.1016/j.jhep.2017.08.029.
2
Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.循环骨桥蛋白水平升高与胆管癌切除术后生存不良有关。
J Hepatol. 2017 Oct;67(4):749-757. doi: 10.1016/j.jhep.2017.06.020. Epub 2017 Jun 29.
3
Reply to: "Is osteopontin a promising prognostic biomarker for cholangiocarcinoma?".
J Hepatol. 2017 Sep 21. doi: 10.1016/j.jhep.2017.08.027.
4
Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.骨桥蛋白在胆管癌病例中的临床病理意义
Asian Pac J Cancer Prev. 2016;17(1):201-5. doi: 10.7314/apjcp.2016.17.1.201.
5
Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.基质的分子谱分析鉴定骨桥蛋白为肝内胆管癌不良预后的独立预测因子。
Hepatology. 2013 Dec;58(6):1992-2000. doi: 10.1002/hep.26577. Epub 2013 Oct 17.
6
Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population.位于-443位点的骨桥蛋白启动子多态性与中国人群肝内胆管癌的转移及不良预后相关。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6914-21. eCollection 2014.
7
Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of β-Catenin.骨桥蛋白通过招募 MAPK1 并介导 β-连环蛋白 Ser675 磷酸化促进肝内胆管癌转移。
Cell Death Dis. 2018 Feb 7;9(2):179. doi: 10.1038/s41419-017-0226-x.
8
Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis.肝星状细胞通过 NR4A2/骨桥蛋白/Wnt 信号轴促进肝内胆管癌的进展。
Oncogene. 2021 Apr;40(16):2910-2922. doi: 10.1038/s41388-021-01705-9. Epub 2021 Mar 19.
9
Circulating osteopontin per tumor volume as a prognostic biomarker for resectable intrahepatic cholangiocarcinoma.每肿瘤体积的循环骨桥蛋白作为可切除性肝内胆管癌的预后生物标志物。
Hepatobiliary Surg Nutr. 2019 Dec;8(6):582-596. doi: 10.21037/hbsn.2019.03.14.
10
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma.代谢综合征患者肝内胆管癌的特征是肿瘤基质中骨桥蛋白过表达。
Int J Mol Sci. 2023 Mar 1;24(5):4748. doi: 10.3390/ijms24054748.
引用本文的文献
1
Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis.骨桥蛋白在骨肉瘤发生发展、转移和预后中的内分泌调节和代谢机制。
Front Endocrinol (Lausanne). 2023 Jan 13;13:1100063. doi: 10.3389/fendo.2022.1100063. eCollection 2022.
2
Osteopontin as a biomarker for osteosarcoma therapy and prognosis.骨桥蛋白作为骨肉瘤治疗和预后的生物标志物。
Oncol Lett. 2019 Mar;17(3):2592-2598. doi: 10.3892/ol.2019.9905. Epub 2019 Jan 8.
Zotero 插件